Zobrazeno 1 - 10
of 16
pro vyhledávání: '"M V Pisarev"'
Autor:
V. I. Podzolkov, M. V. Pisarev
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 19, Iss 3 (2020)
The review provides data on a modern cardiovascular risk management according to Russian and European guidelines Particular emphasis is placed on residual cardiovascular risk and related marker — atherogenic dyslipidemia. The contribution of residu
Externí odkaz:
https://doaj.org/article/a2089dfcbcfd4defae678fb67c006719
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 11, Pp 89-95 (2018)
Reninangiotensinaldosterone axis activation is an important mechanism of hypertension and its cardiovascular and renal complications. Angiotensin receptor blockers are considered among the firstchoice antihypertensive drugs in Russia, European
Externí odkaz:
https://doaj.org/article/eebfae63b0ef438caf2f3c9c07ae4c82
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 14, Iss 4, Pp 591-597 (2018)
The metabolic syndrome is a highly prevalent condition associated with increased cardiovascular risk in the population. Microvasculature is the terminal part of the cardiovascular system which primarily reacts to the increased secretion of the pro in
Externí odkaz:
https://doaj.org/article/906129188ec04d83ad9deaeb5671625a
Autor:
V. I. Podzolkov, T. V. Koroleva, A. E. Bragina, M. G. Kudryavtseva, G. I. Bragina, M. V. Pisarev
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 14, Iss 3, Pp 344-349 (2018)
Aim. To study the erythrocyte electric charge (EEC) in patients with metabolic syndrome (MS).Material and methods. 112 patients (mean age 61.4±7.2 years) with MS (average duration of MS 8.7±5.2 years) were examined. Control group consisted of healt
Externí odkaz:
https://doaj.org/article/5cd8f322d2184719bbaacc6c94cb06fb
Autor:
V. I. Podzolkov, T. V. Koroleva, A. Е. Bragina, M. G. Kudryavtseva, N. A. Druzhinina, M. V. Pisarev
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 14, Iss 2, Pp 184-189 (2018)
Aim. To study the erythrocyte electric charge (EEC) in patients with metabolic syndrome (MS) depending on glycemia levels. Material and methods. 112 patients (45 men and 67 women, age 61.4Ѓ}7.2 years) with MS (MS duration 8.7Ѓ}5.2 years) were studi
Externí odkaz:
https://doaj.org/article/51ecf4ccfcbf4d2f8f5b6688b8836e5a
Autor:
V. I. Podzolkov, M. V. Pisarev
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 13, Iss 3, Pp 383-390 (2017)
An increase in the activity of the renin-angiotensin-aldosterone system is one of the most important mechanisms for the realization of the cardiovascular continuum. The role that angiotensin receptor blockers play in achieving target figures of blood
Externí odkaz:
https://doaj.org/article/4f124810315a4378b94105006e67706b
Publikováno v:
European Heart Journal. 41
Aim To study the influence of epicardial fat tissue (EFT) on atrial fibrillation (AF) occurrence in hypertensive patients. Materials and methods The study included 195 patients with hypertension aged from 38 to 72 years (mean age was 61.5±1.8 years)
Autor:
A. I. Tarzimanova, A. E. Bragina, M V Pisarev, Valery Podzolkov, K A Oganesian, R. G. Gataulin
Publikováno v:
EP Europace. 22
Objective To study the changes in arterial stiffness in patients with obesity and paroxysmal atrial fibrillation (AF). Materials and methods The study included 82 obese patients. Forty-two of them (group I) had paroxysmal AF, their mean age was 60.9
Publikováno v:
Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 14, Iss 4, Pp 591-597 (2018)
The metabolic syndrome is a highly prevalent condition associated with increased cardiovascular risk in the population. Microvasculature is the terminal part of the cardiovascular system which primarily reacts to the increased secretion of the pro in
Autor:
M. G. Kudryavtseva, A. E. Bragina, T. V. Koroleva, Galina I. Bragina, Valery Podzolkov, M. V. Pisarev
Publikováno v:
Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 14, Iss 3, Pp 344-349 (2018)
Aim. To study the erythrocyte electric charge (EEC) in patients with metabolic syndrome (MS).Material and methods. 112 patients (mean age 61.4±7.2 years) with MS (average duration of MS 8.7±5.2 years) were examined. Control group consisted of healt